Chronotherapy With Valsartan/Hydrochlorothiazide Combination in Essential Hypertension: Improved Sleep-Time Blood Pressure Control With Bedtime Dosing

REFERENCES

• Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. (2007). Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension 49:1235–1241.
   PubMed Web of Science ®Google Scholar
• Blacher J, Gasowski J, Staessen JA, Girerd X, This L, Liu L, Wang JG, Fagard R, Safar ME. (2000). Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch. Intern. Med. 160:1085–1089.
   PubMed Web of Science ®Google Scholar
• Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'Brien E, Staessen JA. (2007). Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370:1219–1229.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Rocella EJ. (2003). Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206–1252.
   PubMed Web of Science ®Google Scholar
• Dezii CM. (2000). A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension. Managed Care 9(9 Suppl ):2–6.
   Google Scholar
• Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. (2005). Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin Outcome Study. Hypertension 46:156–161.
   PubMed Web of Science ®Google Scholar
• Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJG, Phillips BB, Zimmerman MB, Bergus BR. (2006). Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 47:352–358.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. (2008). Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 51:55–61.
   PubMed Web of Science ®Google Scholar
• Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, Björklund-Bodegard K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Ibsen H, O'Brien E, Wang J, Staessen JA. (2010). Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J. Hypertens. 28:2036–2045.
   PubMed Web of Science ®Google Scholar
• Fernández JR, Hermida RC. (1998). Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol. Int. 15:191–204.
   PubMed Web of Science ®Google Scholar
• Fernández JR, Mojón A, Hermida RC. (2004). Comparison of parameters from rhythmometric models with multiple components on hybrid data. Chronobiol. Int. 21:467–482.
   Web of Science ®Google Scholar
• Hansson L, Hedner T, Dahlöf B. (1992). Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Blood Press. 1:113–119.
   PubMedGoogle Scholar
• Hermida RC, Calvo C, Ayala DE, Fernández JR, Covelo M, Mojón A, López JE. (2005). Treatment of non-dipper hypertension with bedtime administration of valsartan. J. Hypertens. 23:1913–1922.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Calvo C. (2007a). Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 50:715–722.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. Fernandez JR, Mojón A, Calvo C. (2007b). Influence of measurement duration and frequency on ambulatory blood pressure monitoring. Rev. Esp. Cardiol. 60:131–138.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Calvo C. (2008a). Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 51:69–76.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Chayán L, Domínguez MJ, Fontao MJ, Soler R, Alonso I, Fernández JR. (2008b). Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension. Chronobiol. Int. 25:950–970.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Chayán L, Mojón A, Fernández JR. (2009). Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol. Int. 26:61–79.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. (2010a). Chronotherapy with valsartan/amlodipine combination in essential hypertension: improved blood pressure control with bedtime dosing. Chronobiol. Int. 27:1287–1303.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojon A, Fernandez JR. (2010b). Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol. Int. 27:1629–1651.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH. (2011a). Circadian rhythms: role in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am. J. Hypertens. 24:383–391.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011b). Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J. Am. Coll. Cardiol. In press.
   Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011c). Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care. 34;1270–1276.
   Google Scholar
• Inaba M, Noguchi Y, Yamamoto T, Imai T, Hatano M, Yagi S, Katayama S. (2004). Effects of a low dose of indapamide, a diuretic, given daily or every-other-day on blood pressure and metabolic parameters. Hypertens. Res. 27:141–145.
   PubMed Web of Science ®Google Scholar
• Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. (2005). Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality. The Ohasama Study. Hypertension 45:240–245.
   PubMed Web of Science ®Google Scholar
• Lacourciere Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Kher Y. (2005). Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Clin. Ther. 27:1013–1021.
   PubMed Web of Science ®Google Scholar
• Mallion JM, Carretta R, Trenkwalder P, Martinez JF, Tykarski A, Teitelbaum I, Oddou P, Fagan T. (2003). Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapy. Blood Press. 12( Suppl 1):36–43.
   Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker HAJ, Zanchetti A. (2007). 2007 guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25:1105–1187.
   PubMed Web of Science ®Google Scholar
• Meng Y, Zhang Z, Liang X, Wu C, Qi G. (2010). Effects of combination therapy with amlodipine and fosinopril administered at different times on blood pressure and circadian blood pressure pattern in patients with essential hypertension. Acta Cardiol. 65:309–314.
   PubMed Web of Science ®Google Scholar
• Milani RV. (2005). Reaching for aggressive blood pressure goals: role of angiotensin receptor blockade in combination therapy. Am. J. Manag. Care. 11( Suppl 7):S220–S227.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. (2002). Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20:2183–2189.
   PubMed Web of Science ®Google Scholar
• Palatini P. (2005). Combination therapy in the management of hypertension: focus on angiotensin receptor blockers combined with diuretics. J. Clin. Hypertens. 7:96–101.
   PubMedGoogle Scholar
• Pechère-Bertschi A, Nussberger J, Decosterd L, Armagnac C, Sissmann J, Bouroudian M, Brunner HR, Burnier M. (1998). Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients. J. Hypertens. 16:385–393.
   PubMed Web of Science ®Google Scholar
• Pool JL, Glazer R,Weinberger M, Alvarado R, Huang J, Graff A. (2007). Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults. Clin. Ther. 29:61–73.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 27:1911–1929.
   PubMed Web of Science ®Google Scholar
• Raftery EB, Melville DI, Gould BA, Mann S, Whittington JR. (1981). A study of the antihypertensive action of xipadime using ambulatory intra-arterial monitoring. Br. J. Clin. Pharmacol. 12:381–385.
   PubMed Web of Science ®Google Scholar
• Smith DH, Neutel JM, Lacourciere Y, Kempthorne-Rawson J. (2003). Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements. J. Hypertens. 21:1291–1298.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. (2010). Administration-time-dependent effect of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press. Monit. 15:173–180.
   PubMed Web of Science ®Google Scholar
• Tofé S, García B. (2009). 24-Hour and nighttime blood pressures in type 2 diabetic hypertensive patients following morning or evening administration of olmesartan. J. Clin. Hypertens. (Greenwhich) 11:426–431.
   PubMed Web of Science ®Google Scholar
• Uzu T, Kimura G. (1999). Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 100:1635–1638.
   PubMed Web of Science ®Google Scholar
• Uzu T, Ishikawa K, Fujii T, Nakamura S, Inenaga T, Kimura G. (1997). Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 96:1859–1862.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. (1994). Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 24:793–801.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Reboldi G, Franklin SS, Porcellati C. (2001). Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation 103:2579–2584.
   PubMed Web of Science ®Google Scholar
• Wagstaff AJ. (2006). Valsartan/hydrochlorothiazide: a review of its use in the management of hypertension. Drugs 66:1881–1901.
   PubMed Web of Science ®Google Scholar